Treatment of Mild Class II Malocclusion in Adult Patients With Clear Aligners Versus Fixed Multibracket Therapy
Launched by HAMA UNIVERSITY · Jan 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to treat adults with a mild type of teeth misalignment known as Class II malocclusion. Participants will be divided into two groups: one group will receive treatment using clear aligners with special elastic bands, while the other group will use traditional metal braces with the same types of bands. The study aims to compare how well these two methods work in changing the position of teeth and the overall appearance of the mouth.
To be eligible for this trial, participants should be between 15 and 20 years old, have a specific type of teeth misalignment with a moderate gap between the upper and lower teeth, and should not have had any previous orthodontic treatment. They should also have healthy gums and teeth. Throughout the trial, participants can expect regular check-ups to monitor their progress and the overall changes in their dental and facial structure. This study is important because it will help determine which treatment option is more effective for adults with this specific dental issue.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients with permanent occlusion at age 15-20 years.
- • Patients with class II division I (half cusp or Less) with moderate overjet (2-4mm).
- • Patients with normal or horizontal growth pattern.
- • Mild crowding (_\<2 mm) in maxillary and mandibular arch.
- • Patient with satisfactory periodontal health and good oral hygiene
- • No previous orthodontic treatment
- • Comprehensive medical and dental history ruling out any systemic disease.
- Exclusion Criteria:
- • Patients with periodontal disease.
- • Patients with vertical growth pattern.
- • Patients with missing or extracted teeth except third molar.
- • Patients with temporomandibular joint disorder.
- • Patients with Skeletal open bite.
- • Patients with poor oral and gingival health
- • Patients with neuromuscular disorder.
- • Patients with severe skeletal class II.
About Hama University
Hama University is a leading academic institution dedicated to advancing medical research and clinical trials aimed at improving healthcare outcomes. With a commitment to innovation and excellence, the university collaborates with multidisciplinary teams of researchers, clinicians, and industry partners to develop and evaluate novel therapies and treatment protocols. Hama University’s clinical trial efforts are characterized by rigorous scientific methodology, ethical standards, and a focus on patient-centered outcomes, positioning it as a pivotal contributor to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hama, , Syrian Arab Republic
Patients applied
Trial Officials
FATIMA NASHTR, MSc
Principal Investigator
Hama University
Rabab AlSabbag, Professor
Study Director
Hama University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials